Cabot (CBT) to Release Earnings on Tuesday

Cabot (NYSE:CBT) is anticipated to issue its Q1 2026 results after the market closes on Tuesday, February 3rd. Analysts expect the company to announce earnings of $1.40 per share and revenue of $889.1120 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:00 AM ET.

Cabot (NYSE:CBT) last issued its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). The company had revenue of $899.00 million during the quarter, compared to analyst estimates of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. The business’s revenue for the quarter was down 10.2% compared to the same quarter last year. During the same quarter last year, the company posted $1.80 EPS. On average, analysts expect Cabot to post $8 EPS for the current fiscal year and $8 EPS for the next fiscal year.

Cabot Stock Down 0.0%

NYSE:CBT opened at $72.19 on Monday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.08 and a current ratio of 1.61. The company has a market capitalization of $3.82 billion, a price-to-earnings ratio of 12.01, a price-to-earnings-growth ratio of 3.78 and a beta of 0.88. Cabot has a one year low of $58.33 and a one year high of $89.16. The stock has a 50-day simple moving average of $68.13 and a 200 day simple moving average of $71.66.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Friday, November 28th were paid a dividend of $0.45 per share. The ex-dividend date was Friday, November 28th. This represents a $1.80 annualized dividend and a yield of 2.5%. Cabot’s dividend payout ratio (DPR) is 29.95%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CBT shares. Jefferies Financial Group reaffirmed a “buy” rating and issued a $81.00 price objective on shares of Cabot in a report on Thursday, January 8th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Mizuho boosted their price objective on shares of Cabot from $72.00 to $80.00 and gave the company an “outperform” rating in a research report on Thursday, December 18th. JPMorgan Chase & Co. dropped their price objective on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating on the stock in a research note on Friday, November 28th. Finally, UBS Group lifted their target price on Cabot from $65.00 to $74.00 and gave the company a “neutral” rating in a research note on Monday, January 12th. Two equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $72.25.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in CBT. Danske Bank A S acquired a new stake in Cabot in the third quarter worth about $38,000. Geneos Wealth Management Inc. raised its position in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 364 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in shares of Cabot by 709.1% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock worth $41,000 after acquiring an additional 468 shares during the period. Advisory Services Network LLC acquired a new position in shares of Cabot during the third quarter valued at approximately $57,000. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Cabot by 344.3% during the second quarter. EverSource Wealth Advisors LLC now owns 813 shares of the specialty chemicals company’s stock valued at $61,000 after acquiring an additional 630 shares during the period. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.